Sébastien Monette

6.8k total citations · 1 hit paper
129 papers, 3.7k citations indexed

About

Sébastien Monette is a scholar working on Molecular Biology, Biomedical Engineering and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Sébastien Monette has authored 129 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 28 papers in Biomedical Engineering and 26 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Sébastien Monette's work include Microbial Inactivation Methods (16 papers), Microfluidic and Bio-sensing Technologies (10 papers) and Virus-based gene therapy research (10 papers). Sébastien Monette is often cited by papers focused on Microbial Inactivation Methods (16 papers), Microfluidic and Bio-sensing Technologies (10 papers) and Virus-based gene therapy research (10 papers). Sébastien Monette collaborates with scholars based in United States, Germany and Austria. Sébastien Monette's co-authors include Stephen B. Solomon, Carl Blobel, Majid Maybody, Philip J. Bergman, Paula C. Ezell, Pat Zanzonico, Jonathan Coleman, Gordon W. Single, Kai Ma and Michelle S. Bradbury and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Sébastien Monette

125 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Ultrasmall nanoparticles induce ferroptosis in nutrient-deprived cancer cells and suppress tumour growth

2016 507 citations Kai Ma, Feng Chen et al. Nature Nanotechnology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sébastien Monette United States	32	1.2k	793	677	579	484	129	3.7k
Ivo Que Netherlands	34	1.5k 1.3×	954 1.2×	507 0.7×	807 1.4×	200 0.4×	85	4.0k
Jazli Aziz Malaysia	6	1.5k 1.3×	1.2k 1.5×	505 0.7×	1.1k 2.0×	133 0.3×	10	5.7k
Pauline Chu United States	22	1.5k 1.2×	816 1.0×	192 0.3×	544 0.9×	168 0.3×	29	3.1k
Jiří Bártek Denmark	41	2.2k 1.9×	345 0.4×	671 1.0×	2.0k 3.4×	252 0.5×	168	6.4k
Eric L. Kaijzel Netherlands	31	711 0.6×	676 0.9×	310 0.5×	279 0.5×	138 0.3×	69	2.5k
Catharina de Lange Davies Norway	39	1.4k 1.1×	2.2k 2.8×	321 0.5×	517 0.9×	143 0.3×	128	4.6k
Hiroshi Nishihara Japan	41	2.4k 2.0×	555 0.7×	1.2k 1.7×	1.7k 3.0×	147 0.3×	335	6.1k
David J. Argyle United Kingdom	28	860 0.7×	261 0.3×	713 1.1×	530 0.9×	149 0.3×	96	2.7k
María José Oliveira Portugal	41	2.0k 1.7×	617 0.8×	526 0.8×	1.3k 2.3×	169 0.3×	130	4.9k
Edward V. Maytin United States	40	1.3k 1.1×	1.2k 1.5×	1.5k 2.2×	307 0.5×	138 0.3×	122	3.9k

Countries citing papers authored by Sébastien Monette

Since Specialization

Citations

This map shows the geographic impact of Sébastien Monette's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sébastien Monette with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sébastien Monette more than expected).

Fields of papers citing papers by Sébastien Monette

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sébastien Monette. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sébastien Monette. The network helps show where Sébastien Monette may publish in the future.

Co-authorship network of co-authors of Sébastien Monette

This figure shows the co-authorship network connecting the top 25 collaborators of Sébastien Monette. A scholar is included among the top collaborators of Sébastien Monette based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sébastien Monette. Sébastien Monette is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fung, Edward K., Sang Gyu Lee, Sébastien Monette, et al.. (2025). GPA33-pretargeted radioimmunotherapy with mono- and bivalent DOTA-based Lu-177-labeled radiohaptens in a mouse orthotopic liver xenograft model of metastatic human colorectal cancer. Theranostics. 15(13). 6274–6289. 2 indexed citations

Leon, Gabriel De, Feng Chen, Tuo Zhang, et al.. (2025). An ultrasmall core–shell silica nanoparticle improves antitumour immunity and survival by remodelling suppressive melanoma microenvironments. Nature Nanotechnology. 21(2). 311–322.

Nacev, Benjamin A., Matthew R. Paul, Michelle M. Mitchener, et al.. (2024). Cancer-associated Histone H3 N-terminal arginine mutations disrupt PRC2 activity and impair differentiation. Nature Communications. 15(1). 5155–5155. 4 indexed citations

Larney, Benedict Mc, Ali Yasin Sonay, Sébastien Monette, et al.. (2024). A pan-cancer dye for solid-tumour screening, resection and wound monitoring via short-wave and near-infrared fluorescence imaging. Nature Biomedical Engineering. 8(9). 1092–1108. 10 indexed citations

Rosenberg, Jonathan B., Bishnu P. De, Alvin Chen, et al.. (2023). Safety of Intravenous Administration of an AAV8 Vector Coding for an Oxidation-Resistant Human α1-Antitrypsin for the Treatment of α1-Antitrypsin Deficiency. Human Gene Therapy. 34(3-4). 139–149. 4 indexed citations

Carter, Lukas M., et al.. (2023). Statins enhance the efficacy of HER2-targeting radioligand therapy in drug-resistant gastric cancers. Proceedings of the National Academy of Sciences. 120(14). e2220413120–e2220413120. 18 indexed citations

De, Bishnu P., Jonathan B. Rosenberg, Stephen M. Kaminsky, et al.. (2023). Assessment of Safety and Biodistribution of AAVrh.10hCLN2 Following Intracisternal Administration in Nonhuman Primates for the Treatment of CLN2 Batten Disease. Human Gene Therapy. 34(17-18). 905–916. 5 indexed citations

Aditya, Anusha, Feng Chen, Barney Yoo, et al.. (2022). Ultrasmall Nanoparticle Delivery of Doxorubicin Improves Therapeutic Index for High-Grade Glioma. Clinical Cancer Research. 28(13). 2938–2952. 14 indexed citations

Monette, Sébastien, Adam O. Michel, Achiude Bendet, et al.. (2021). Transarterial Embolization of Liver Cancer in a Transgenic Pig Model. Journal of Vascular and Interventional Radiology. 32(4). 510–517.e3. 25 indexed citations

10.

Chung, Sebastian, Darren R. Veach, Edward K. Fung, et al.. (2021). Intraperitoneal Pretargeted Radioimmunotherapy for Colorectal Peritoneal Carcinomatosis. Molecular Cancer Therapeutics. 21(1). 125–137. 11 indexed citations

11.

Monette, Sébastien, et al.. (2021). Radiation Exposure and Coronary Atherosclerosis: Differential Effect of the Radiation Site. Journal of the American Society of Nephrology. 32(10S). 568–569.

12.

Michel, Adam O., Taryn Donovan, Ben Roediger, et al.. (2021). Chaphamaparvovirus antigen and nucleic acids are not detected in kidney tissues from cats with chronic renal disease or immunocompromised cats. Veterinary Pathology. 59(1). 120–126. 1 indexed citations

13.

Mayer, Christian T., Anna Gazumyan, Melissa Cipolla, et al.. (2020). An apoptosis-dependent checkpoint for autoimmunity in memory B and plasma cells. Proceedings of the National Academy of Sciences. 117(40). 24957–24963. 12 indexed citations

14.

Lee, Quintin, Matthew P. Padula, Natalia Pinello, et al.. (2020). Murine and related chapparvoviruses are nephro-tropic and produce novel accessory proteins in infected kidneys. PLoS Pathogens. 16(1). e1008262–e1008262. 24 indexed citations

15.

Yarmohammadi, Hooman, Masashi Fujimori, Sébastien Monette, et al.. (2019). Abstract No. 617 Nonthermal ablation of pancreatic cancer in a pig model, using vascular-targeted photodynamic therapy (VTP). Journal of Vascular and Interventional Radiology. 30(3). S266–S266. 1 indexed citations

16.

Kim, Kwanghee, Philip A. Watson, Souhil Lebdai, et al.. (2018). Androgen Deprivation Therapy Potentiates the Efficacy of Vascular Targeted Photodynamic Therapy of Prostate Cancer Xenografts. Clinical Cancer Research. 24(10). 2408–2416. 17 indexed citations

17.

Sharma, Sai Kiran, Andrew Chow, Sébastien Monette, et al.. (2018). Fc-Mediated Anomalous Biodistribution of Therapeutic Antibodies in Immunodeficient Mouse Models. Cancer Research. 78(7). 1820–1832. 81 indexed citations

18.

Rosenberg, Jonathan B., Michael G. Kaplitt, Bishnu P. De, et al.. (2018). AAVrh.10-Mediated APOE2 Central Nervous System Gene Therapy for APOE4-Associated Alzheimer's Disease. PubMed. 29(1). 24–47. 123 indexed citations

19.

O’Shaughnessy, Matthew J., Katie S. Murray, Sadna Budhu, et al.. (2017). Systemic Antitumor Immunity by PD-1/PD-L1 Inhibition Is Potentiated by Vascular-Targeted Photodynamic Therapy of Primary Tumors. Clinical Cancer Research. 24(3). 592–599. 76 indexed citations

20.

Kaminsky, Stephen M., Sébastien Monette, Jacob Rosenberg, et al.. (2013). Safety of Direct Cardiac Administration of AdVEGF-All6A+, a Replication Deficient Adenovirus Vector cDNA/Genomic Hybrid Expressing All Three Major Isoforms of Human Vascular Endothelial Growth Factor, to the Ischemic Myocardium of Rats. 2900110453–2900110453. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact